Malignant tumor
Conditions
Interventions
Index test:Nano 
nose 
early 
diagnosis 
and 
screening 
model 
of 
tumor
Sponsors
Anhui Cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Malignant tumor group: 1. aged >= 18 years, gender is not limited. 2. primary criteria for the determination of primary tumors. 3. total bilirubin = 18 years, gender is not limited. 2. imaging or histopathology suggestive of patients with benign lesions. 3. blood biochemical urea nitrogen <= 1.25 x upper limit of normal (UNL), creatinine <= 1.25 x UNL. 4. total bilirubin <= 1.5 x UNL, aspartate aminotransferase AST (SGOT) and alanine aminotransferase ALT (SGPT) <= 2.5 x UNL. 5. No smoking or drinking in the past week. 6. All patients should be informed consent. Healthy control group: healthy patients who were screened for physical examination at the physical examination center, no history of acute disease in the past two weeks, no history of smoking and drinking in the past week, and patients with informed consent.
Exclusion criteria
Exclusion criteria: Malignant tumor group: 1. Patients without self-knowledge ability. 2. Simultaneously combine with a malignant tumor other than a malignant tumor. 3. Combined with other diseases, such as diabetes, hyperlipidemia, severe hypertension, kidney disease, hyperthyroidism, uncontrolled psychosis; any acute disease symptoms (respiratory inflammatory diseases, active infections) occurred in the past 2 weeks. 4. In the past 2 weeks, drugs that affect metabolism, such as antibiotics (penicillins, erythromycin), hormones (deoxycortisol, dexamethasone), non-steroidal anti-inflammatory drugs (aspirin, granulitis), were used. 5. Previously received radiotherapy, surgery or interventional therapy. 6. There is a significant abnormality in the ventilation of the lungs. 7. pregnant or lactating women. Benign disease group: 1. Patients without self-knowledge ability. 2. There is a history of malignant tumors. 3. In combination with other diseases affecting metabolism and any acute disease symptoms in the past 2 weeks, there are obvious abnormalities in ventilation and ventilation of the lungs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volatile organic compounds, VOCs;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactHu Liu
Anhui Cancer Hospital
Outcome results
None listed